Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.
about
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent mannerNucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.Poke weed mitogen requires Toll-like receptor ligands for proliferative activity in human and murine B lymphocytes.FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responsesCpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanismCyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammationCell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP miceCpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.Accessory molecules for Toll-like receptors and their function.Absence of surrogate light chain results in spontaneous autoreactive germinal centres expanding V(H)81X-expressing B cells.B cells do not take up bacterial DNA: an essential role for antigen in exposure of DNA to toll-like receptor-9.T cell-dependent antigen adjuvanted with DOTAP-CpG-B but not DOTAP-CpG-A induces robust germinal center responses and high affinity antibodies in mice.B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids.Selective binding of anti-DNA antibodies to native dsDNA fragments of differing sequenceDCs facilitate B cell responses against microbial DNA via DC-SIGN.Systemic lupus erythematosus.B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
P2860
Q33902560-A1D7D358-1FA5-433E-9CD2-1B82BCF31D41Q34017633-D9E92D3D-8CE0-4D72-A29D-17706ECA2267Q34125267-E19D018E-7995-4FB8-AA3D-C0F4DC4002DFQ34699337-93436F05-152F-4CCB-888B-B00C277F5942Q35204579-1CF62FBE-D3B5-4E95-889D-027ECB5825E4Q35212596-B04767FE-2DE6-4482-B464-7B7B010952D4Q36516826-D682C895-D462-4D89-9BFE-BD4B638DF61CQ37710236-0941C7A3-7C18-4326-BF0A-811A100F0FAFQ37758263-3CA378F5-5441-4960-B982-696CED9692F9Q37956536-1E2CE23B-7D90-4575-A2D6-3AF2E2713EC3Q37981048-DFB111CB-5FA0-4F83-AF17-659D05595FB2Q38877086-298FE6D6-EE82-42A3-B128-682A759364A6Q39648141-3CD604DE-64DA-419D-9C35-EE0AED028479Q40111632-5BE4B1CD-ECAA-4B43-B0DB-7A32319197C6Q40157161-1614D8B0-8DB2-43D5-8E04-F4E64B527EFEQ40755811-E68D9D8A-B9D5-40C9-9A97-A7AADF4921D6Q42370224-14109B67-F5D3-42C0-92F5-1E67F621C0EBQ50848358-247201F9-C2C9-4154-AE6E-9C0C548AC499Q53314342-DF30F790-14B9-43F0-AA9B-60CAF4DDA925
P2860
Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Differential cytokine producti ...... -A and CpG-B oligonucleotides.
@ast
Differential cytokine producti ...... -A and CpG-B oligonucleotides.
@en
type
label
Differential cytokine producti ...... -A and CpG-B oligonucleotides.
@ast
Differential cytokine producti ...... -A and CpG-B oligonucleotides.
@en
prefLabel
Differential cytokine producti ...... -A and CpG-B oligonucleotides.
@ast
Differential cytokine producti ...... -A and CpG-B oligonucleotides.
@en
P2093
P2860
P356
P1476
Differential cytokine producti ...... -A and CpG-B oligonucleotides.
@en
P2093
Ana M Avalos
Ann Marshak-Rothstein
Betty Mousseau
Eicke Latz
Frances Lund
Mark J Shlomchik
Sean R Christensen
P2860
P304
P356
10.4049/JIMMUNOL.0901941
P407
P577
2009-10-28T00:00:00Z